Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
ApexBio/AZD2461/10mM (in 1mL DMSO)/A4164188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

ApexBio/AZD2461/10mM (in 1mL DMSO)/A4164

Related Products
  • XAV-939
  • ABT-888 (Veliparib)
  • BMN-673 8R,9S
  • MK-4827
  • PJ34
Molarity CalculatorDilution Calculator
AZD2461Novel PARP inhibitor

Catalog No.A4164
SizePriceStockQty
10mM (in 1mL DMSO)
$119.00
In stock
5mg
$75.00
In stock
10mg
$120.00
In stock
50mg
$380.00
In stock
100mg
$540.00
In stock

Tel: +1-832-696-8203

Email: sales@apexbt.com

Worldwide Distributors

Sample solution is provided at 25 µL, 10mM.

Publications citing ApexBio Products

Nature.2017 Jan 19;541(7637):417-420.
Nature.2018 Nov;563(7731):407-411.
Nature.2018 Jun 13.
Nature.2018 Jun 27.
Nature.2018 Mar 29;555(7698):673-677.
Nature.2017 Sep 7;549(7670):96-100.
Nature.2016 Apr 21;532(7599):398-401.
Science.2016 Aug 5;353(6299)594-8
Nat Nanotechnol.2017 Dec;12(12):1190-1198.
Nature Biotechnology.2017 Jun;35(6):569-576
Nat Med.2018 Sep 17.
Cell.2018 Dec 21. pii: S0092-8674(18)31561-7.
Cell.Available online 25 October 2018.
Cell.2018 Sep 27. pii: S0092-8674(18)31183-8.
Cell.2018 Jun 28;174(1):172-186.e21.
Cell.2018 Feb 22;172(5):1007-1021.e17.
Cell.2017 Nov 30;171(6):1284-1300.e21.
Cell.2017 Aug 17. pii: S0092-8674(17)30869-3.
Cell.2017 Jul 13;170(2):312-323
Nat Med.2018 Jan 29.
Nat Med.2017 Nov;23(11):1342-1351.
Cell.2017 Apr 6;169(2):286-300.
Cell.2015 Aug 27;162(5):987-1002.
Cell.2015 Feb 12;160(4):729-44.
Nature Medicine.2017 Apr;23(4):493-500.
Cancer Cell.2018 May 14;33(5):905-921.e5.
Cancer Cell.2018 Apr 9;33(4):752-769.e8.
Cancer Cell.2018 Mar 12;33(3):401-416.e8.
Cancer Cell.2017 Aug 14;32(2):253-267.e5.
Nat Methods.2018 Jul;15(7):523-526.
Cell Stem Cell.2018 May 3;22(5):769-778.e4.
Cell Stem Cell.2017 Nov 20. pii: S1934-5909(17)30375-2.

Related Compound Libraries

  • DiscoveryProbe™ Bioactive Compound Library
  • DiscoveryProbe™ Anti-cancer Compound Library
  • DiscoveryProbe™ Epigenetics Compound Library
  • DiscoveryProbe™ DNA Damage/DNA Repair Library

Quality Control

Quality Control & MSDS

View current batch:
    Purity = 98.00%
  • COA (Certificate Of Analysis)
  • MSDS (Material Safety Data Sheet)
  • Datasheet

Chemical structure

AZD2461

Biological Activity

DescriptionAZD2461 is a novel inhibitor of PARP.
TargetsPARP
IC50

Protocol

Cell experiment [1]:

Cell lines

human MCF-7 and SKBr-3 breast cancer cells

Preparation method

The solubility of this compound in DMSO is >16.35mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.

Reacting condition

5-50 μM, 48 and 72h

Applications

In human MCF-7 and SKBr-3 breast cancer cells, AZD2461 was cytotoxic and reduced numbers of viable cells in a concentration- and time-dependent manner. PARP-1 inhibition by AZD2461 (10 μM for 48h) increased proportions of MCF-7 cells in the G2 phase and reduced cells in S-phase.

Animal experiment [2]:

Animal models

mice with KB1P tumors

Dosage form

100 mg/kg p.o., 28 consecutive days or 100 consecutive days

Application

In mice with KB1P tumors, AZD2461 completely inhibited the PARP activity for several hours and the amount of PARP returned to baseline levels 24 hours after treatment. AZD2461 had lower affinity for Pgp than did olaparib. Mice treated with AZD2461 for 28 consecutive days showed increased survival. When treatment with AZD2461 for 100 consecutive days, 8 of 9 mice engrafted with fragments from 3 individual KB1P tumors did not develop refractory tumors within 300 days after treatment start. Long-term AZD2461 treatment was well tolerated and doubled the median relapse-free survival from 64 to 132 days.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Wsierska GJ, Heinzl S. Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells. J Cancer Prev. 2014, 19(2): 125–136.

[2]. Jaspers JE, Kersbergen A, Boon U, et al. Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1-Mutated Mouse Mammary Tumors. Cancer Discov, 2013, 3(1): 68-81.

AZD2461 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
C1
V1
C2
V2

calculate

AZD2461 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
g/mol

calculate

Chemical Properties

Cas No. 1174043-16-3SDF Download SDF
Chemical Name 4-[[4-fluoro-3-(4-methoxypiperidine-1-carbonyl)phenyl]methyl]-2H-phthalazin-1-one
Canonical SMILES COC1CCN(CC1)C(=O)C2=C(C=CC(=C2)CC3=NNC(=O)C4=CC=CC=C43)F
Formula C22H22FN3O3 M.Wt 395.43
Solubility ≥16.35 mg/mL in DMSO, ≥45.2 mg/mL in EtOH with ultrasonic, <2.37 mg/ml="" in="" h2o=""> Storage Store at -20°C
Physical AppearanceA solidShipping ConditionEvaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.

Background

AZD2461 is a novel PARP inhibitor with IC50 value of 5nM [1].Poly (ADP-ribose) polymerase (PARP) is a family of proteins involved in a number of cellular processes involving mainly DNA repair and programmed cell death [1].In SKBR-3 line and MCF-7 line, AZD2461 was cytotoxic and reduced numbers of viable cells in a concentration- and time-dependent manner. Also, through inhibiting PARP-1, AZD2461 increased MCF-7 cells and SKBR-3 cells in the G2 phase at the expense of proportions in the S- phase, respectively [2].In order to investigate whether long-term dosing of AZD2461 would be capable of causing eradication or chronic suppression of KB1P tumors, which acquired Pgp-mediated resistance, we tested the response of KB1P tumors to the novel AZD2461. Both AZD2461 and olaparib completely inhibited the PARP activity for several hours, and 24 hours after treatment the amount of PAR returned to baseline levels. These data show that AZD2461 is a novel PARPi with potential to bypass Pgp-mediated resistance to olaparib. With short-term treatment, AZD2461 induces loss of 53BP1 expression in mice with KB1P tumors. Long-term AZD2461 treatment is well tolerated and doubled the median relapse-free survival [1].Reference:[1]. Jaspers JE, Kersbergen A, Boon U, et al. Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1-Mutated Mouse Mammary Tumors. Cancer Discov, 2013, 3(1): 68-81.[2]. Węsierska GJ, Heinzl S. Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells. J Cancer Prev. 2014, 19(2): 125–136.

新闻动态
行业前沿
技术文章
最新产品